Marché mondial de la neurophotonique – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché de la neurophotonique

Le neurodiagnostic, en tant qu'application du marché de la neurophotonique, implique l'utilisation de technologies optiques pour diagnostiquer et surveiller les troubles neurologiques. Des techniques telles que la spectroscopie proche infrarouge (NIRS) et la spectroscopie proche infrarouge fonctionnelle (fNIRS) permettent une mesure non invasive de l'activité cérébrale en détectant les changements dans l'oxygénation du sang et l'hémodynamique. Ces méthodes fournissent des informations en temps réel sur le fonctionnement du cerveau, facilitant le diagnostic de troubles tels que les accidents vasculaires cérébraux, les lésions cérébrales traumatiques et les troubles cognitifs.

Français La taille du marché mondial de la neurophotonique était évaluée à 1,56 milliard USD en 2023 et devrait atteindre 3,56 milliards USD d'ici 2031, avec un TCAC de 10,88 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée du rapport et segmentation du marché       

Définition du marché

La neurophotonique est un domaine qui combine les neurosciences et la photonique pour étudier le cerveau à l'aide de technologies basées sur la lumière. Elle implique l'utilisation de méthodes optiques, telles que l'imagerie laser et la spectroscopie, pour visualiser et manipuler l'activité neuronale. Cette approche permet une observation et un contrôle à haute résolution et non invasifs des fonctions cérébrales, faisant progresser notre compréhension des processus neuronaux et contribuant au développement de traitements pour les troubles neurologiques.

Dynamique du marché de la neurophotonique

Drivers                                                                                          

• Escalating Investments in Research and Development

High investments fuel groundbreaking discoveries and technological advancements, fostering the creation of innovative neurophotonics tools and applications. With governments, academic institutions, and private enterprises allocating substantial funds to neuroscience R&D, there's a surge in collaborative efforts and interdisciplinary research initiatives. This concerted focus on R&D enhances our understanding of neural processes, spurring the development of more sophisticated neurophotonics solutions for diagnostics, therapeutics, and basic neuroscience research. These investments stimulate market growth and hold the promise of revolutionizing neurological healthcare with cutting-edge optical technologies.

• Increased Focus on Precision Medicine

Precision medicine emphasizes tailoring medical treatments to individual characteristics, including genetic makeup, lifestyle, and environmental factors. Neurophotonics plays a crucial role in precision medicine by providing non-invasive, high-resolution imaging techniques for detailed mapping of neural structures and functions. This precision allows healthcare providers to diagnose neurological disorders more accurately, predict treatment responses, and personalize therapeutic interventions for better patient outcomes. As the demand for personalized healthcare grows, the adoption of neurophotonics technologies is expected to increase, driving market expansion and innovation in the field.

Opportunities

• Growing Prevalence of Neurological Disorders

Conditions such as Alzheimer's disease, Parkinson's disease, and stroke is rising globally due to which there's a growing demand for advanced diagnostic and therapeutic solutions. Neurophotonics technologies offer non-invasive and high-resolution imaging methods, enabling early detection, precise diagnosis, and monitoring of these disorders. Additionally, the complexity of neurological conditions necessitates better understanding of brain function, which neurophotonics facilitates through its ability to visualize neural activity in real-time. This demand is further fueled by the healthcare industry's focus on providing more personalized and targeted treatments, driving investment and innovation in neurophotonics research and development.

• High Advancements in Technology

These advancements have led to the development of innovative products and solutions that improve the diagnosis and treatment of neurological disorders. Technological advancements in pain management, for instance, have contributed to the growth of the neurophotonics market. Additionally, advancements in imaging and sensing technologies have enhanced the accuracy and effectiveness of neurophotonics-based treatments. These advancements are expected to continue driving market growth in the future.

Restraints/Challenges

• High Initial Investment Required

The substantial cost associated with purchasing advanced equipment, such as imaging systems and laser devices, as well as the expenses related to training personnel and maintaining the infrastructure, can deter healthcare facilities and research institutions from adopting neurophotonics solutions. This financial barrier limits access to cutting-edge neurodiagnostic and therapeutic technologies, particularly for organizations with constrained budgets or in developing regions.

• Increased Privacy Concerns

The use of neurophotonics technologies for brain imaging and manipulation raises ethical questions regarding the collection, storage, and sharing of sensitive neuroimaging data. Patients and research participants may have concerns about the potential misuse or unauthorized access to their neural information, leading to hesitancy in participating in neurophotonics studies or undergoing neuroimaging procedures. Regulatory frameworks for protecting patient privacy and ensuring data security are essential but can also add complexity and compliance burdens for neuroph otonics developers and healthcare providers.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Neurophotonics Market Scope

The market is segmented on the basis of type, application, and end-use. The growth amongst these segments will help your meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Type

• Microscopy
• Spectroscopy
• Multimodal

Application

• Research
• Diagnostics
• Therapeutics

End-Use

• Hospitals
• Clinics
• Others

Neurophotonics Market Regional Analysis/Insights

The market is analyzed, and market size insights and trends are provided by country, type, application and end-use as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.   

North America dominates the market due to substantial healthcare expenditures and improved healthcare outcomes, particularly in the U.S. This dominance is driven by significant investments in medical research and advanced healthcare technologies, which enhance diagnostic and therapeutic capabilities. Additionally, a strong focus on innovation and the presence of leading healthcare institutions contribute to the region's prominent position in the market.

Asia-Pacific is expected to experience significant growth in the market, primarily due to substantial investments in research and development. This region's robust scientific community, combined with increasing government funding and collaboration between academic institutions and industry, drives advancements in neurophotonics technology. Additionally, the growing prevalence of neurological disorders and the rising demand for innovative diagnostic and therapeutic solutions further boost market growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Neurophotonics Market Analysis

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché mondial des maisons de retraite et des établissements de soins de longue durée.

Certains des principaux acteurs opérant sur le marché sont :

•  Hitachi, Ltd (Japon)
•  Artinis Medical Systems (Pays-Bas)
•  Cairn Research (Royaume-Uni)
•  Femtonics Ltd (Hongrie)
•  Carl Zeiss AG (Allemagne)
•  fNIR Devices LLC (États-Unis)
•  HemoPhotonics (Espagne)
•  Horiba, Ltd. (Japon)
•  Leica Microsystems (Allemagne)
•  Innovations en matière d'imagerie intelligente (États-Unis)

SKU-61765